Goldman Sachs’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-147,421
| Closed | -$19.4M | – | 5529 |
|
|
2020
Q4 | $19.4M | Buy |
147,421
+123,062
| +505% | +$16.2M | 0.01% | 1582 |
|
|
2020
Q3 | $1.23M | Sell |
24,359
-7,741
| -24% | -$391K | ﹤0.01% | 3194 |
|
|
2020
Q2 | $1.53M | Sell |
32,100
-2,767
| -8% | -$132K | ﹤0.01% | 2983 |
|
|
2020
Q1 | $1.71M | Sell |
34,867
-16,131
| -32% | -$790K | ﹤0.01% | 2837 |
|
|
2019
Q4 | $2.93M | Buy |
50,998
+14,404
| +39% | +$827K | ﹤0.01% | 2740 |
|
|
2019
Q3 | $1.32M | Buy |
36,594
+17,929
| +96% | +$645K | ﹤0.01% | 3095 |
|
|
2019
Q2 | $580K | Sell |
18,665
-1,063
| -5% | -$33K | ﹤0.01% | 3458 |
|
|
2019
Q1 | $463K | Sell |
19,728
-8,062
| -29% | -$189K | ﹤0.01% | 3591 |
|
|
2018
Q4 | $382K | Buy |
27,790
+12,839
| +86% | +$176K | ﹤0.01% | 3516 |
|
|
2018
Q3 | $149K | Sell |
14,951
-16,741
| -53% | -$167K | ﹤0.01% | 3878 |
|
|
2018
Q2 | $645K | Buy |
+31,692
| New | +$645K | ﹤0.01% | 3413 |
|